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Abstract
We introduce a supervised learning mixture model for censored durations
(C-mix) to simultaneously detect subgroups of patients with different prog-
nosis and order them based on their risk. Our method is applicable in a high-
dimensional setting, i.e. with a large number of biomedical covariates. Indeed,
we penalize the negative log-likelihood by the Elastic-Net, which leads to a
sparse parameterization of the model and automatically pinpoints the relevant
covariates for the survival prediction. Inference is achieved using an efficient
Quasi-Newton Expectation Maximization (QNEM) algorithm, for which we
provide convergence properties. The statistical performance of the method is
examined on an extensive Monte Carlo simulation study, and finally illustrated
on three publicly available genetic cancer datasets with high-dimensional co-
variates. We show that our approach outperforms the state-of-the-art survival
models in this context, namely both the CURE and Cox proportional hazards
models penalized by the Elastic-Net, in terms of C-index, AUC(t) and sur-
vival prediction. Thus, we propose a powerfull tool for personalized medicine
in cancerology.
Keywords. Coxs proportional hazards model; CURE model; Elastic-net reg-
ularization; High-dimensional estimation; Mixture duration model; Survival
analysis
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1 Introduction
Predicting subgroups of patients with different prognosis is a key challenge for per-
sonalized medicine, see for instance Alizadeh et al. [2000] and Rosenwald et al. [2002]
where subgroups of patients with different survival rates are identified based on gene
expression data. A substantial number of techniques can be found in the literature
to predict the subgroup of a given patient in a classification setting, namely when
subgroups are known in advance [Golub et al., 1999, Hastie et al., 2001, Tibshirani
et al., 2002]. We consider in the present paper the much more difficult case where
subgroups are unknown.
In this situation, a first widespread approach consists in first using unsupervised
learning techniques applied on the covariates – for instance on the gene expression
data [Bhattacharjee et al., 2001, Beer et al., 2002, Sørlie et al., 2001] – to define
subsets of patients and then estimating the risks in each of them. The problem of
such techniques is that there is no guarantee that the identified subgroups will have
different risks. Another approach to subgroups identification is conversely based
exclusively on the survival times: patients are then assigned to a low-risk or a high-
risk group based on whether they were still alive [Shipp et al., 2002, Van’t Veer et al.,
2002]. The problem here is that the resulting subgroups may not be biologically
meaningful since the method do not use the covariates, and prognosis prediction
based on covariates is not possible.
The method we propose uses both the survival information of the patients and
its covariates in a supervised learning way. Moreover, it relies on the idea that
exploiting the subgroups structure of the data, namely the fact that a portion of the
population have a higher risk of early death, could improve the survival prediction
of future patients (unseen during the learning phase).
We propose to consider a mixture of event times distributions in which the
probabilities of belonging to each subgroups are driven by the covariates (e.g. gene
expression data, patients characteristics, therapeutic strategy or omics covariates).
Our C-mix model is hence part of the class of model-based clustering algorithms, as
introduced in Banfield and Raftery [1993].
More precisely, to model the heterogeneity within the patient population, we
introduce a latent variable Z ∈ {0, . . . , K − 1} and our focus is on the conditional
distribution of Z given the values of the covariates X = x. Now, conditionally on
the latent variable Z, the distribution of duration time T is different, leading to a
mixture in the event times distribution.
For a patient with covariates x, the conditional probabilities pik(x) = P[Z =
k|X = x] of belonging to the k-th risk group can be seen as scores, that can help
decision-making for physicians. As a byproduct, it can also shed light on the effect
of the covariates (which combination of biomedical markers are relevant to a given
event of interest).
Our methodology differs from the standard survival analysis approaches in var-
ious ways, that we describe in this paragraph. First, the Cox proportional hazards
(PH) model (Cox [1972]) (by far the most widely used in such a setting) is a regres-
sion model that describes the relation between intensity of events and covariates x
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via
λ(t) = λ0(t)exp(x
>βcox), (1)
where λ0 is a baseline intensity, and β
cox is a vector quantifying the multiplicative
impact on the hazard ratio of each covariate. As in our model, high-dimensional
covariates can be handled, via e.g. penalization , see Simon et al. [2011]. But
it does not permit the stratification of the population in groups of homogeneous
risks, hence does no deliver a simple tool for clinical practice. Moreover, we show
in the numerical sections that the C-mix model can be trained very efficiently in
high dimension, and outperforms the standard Cox PH model by far in the analysed
datasets.
Other models condiser mixtures of event times distributions. In the CURE model
(see Farewell [1982] and Kuk and Chen [1992]), one fraction of the population is
considered as cured (hence not subject to any risk). This can be very limitating, as
for a large number of applications (e.g. rehospitalization for patients with chronic
diseases or relapse for patients with metastatic cancer), all patients are at risk. We
consider, in our model, that there is always an event risk, no matter how small.
Other mixture models have been considered in survival analysis: see Kuo and Peng
[2000] for a general study about mixture model for survival data or De Angelis et al.
[1999] in a cancer survival analysis setting, to name but a few. Unlike our algorithm,
none of these algorithms considers the high dimensional setting.
A precise description of the model is given in Section 2. Section 3 focuses on the
regularized version of the model with an Elastic-Net penalization to exploit dimen-
sion reduction and prevent overfitting. Inference is presented under this framework,
as well as the convergence properties of the developed algorithm. Section 4 high-
lights the simulation procedure used to evaluate the performances and compares it
with state-of-the-art models. In Section 5, we apply our method to genetic datasets.
Finally, we discuss the obtained results in Section 6.
2 A censored mixture model
Let us present the survival analysis framework. We assume that, the conditional
density of the duration T given X = x is a mixture
f(t|X = x) =
K−1∑
k=0
pik(x)fk(t;αk)
of K ≥ 1 densities fk, for t ≥ 0 and αk ∈ Rdk some parameters to estimate. The
weights combining these distributions depend on the patient biomedical covariates
x and are such that
K−1∑
k=0
pik(x) = 1. (2)
This is equivalent to saying that conditionally on a latent variable Z = k ∈ {0, . . . , K−
1}, the density of T at time t ≥ 0 is fk(t ;αk), and we have
P[Z = k|X = x] = pik(x) = piβk(x)
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where βk = (βk,1, . . . , βk,d) ∈ Rd denotes a vector of coefficients that quantifies the
impact of each biomedical covariates on the probability that a patient belongs to
the k-th group. Consider a logistic link function for these weights given by
piβk(x) =
ex
>βk∑K−1
k=0 e
x>βk
. (3)
The hidden status Z has therefore a multinomial distributionM(piβ0(x), . . . , piβK−1(x)).
The intercept term is here omitted without loss of generality.
In practice, information loss occurs of right censoring type. This is taken into
acount in our model by introducing the following: a time C ≥ 0 when the individual
“leaves” the target cohort, a right-censored duration Y and a censoring indicator
∆, defined by
Y = min(T,C) and ∆ = 1{T≤C},
where min(a, b) denotes the minimum between two numbers a and b, and 1 denotes
the indicator function.
In order to write a likelihood and draw inference, we make the two following
hypothesis.
Hypothesis 1 T and C are conditionally independent given Z and X.
Hypothesis 2 C is independent of Z.
Hypothesis 1 is classical in survival analysis [Klein and Moeschberger, 2005], while
Hypothesis 2 is classical in survival mixture models [Kuo and Peng, 2000, De Angelis
et al., 1999]. Under this hypothesis, denoting g the density of the censoring C, F
the cumulative distribution function corresponding to a given density f , F¯ = 1−F
and F (y−) = lim
u→y
u≤y
F (u), we have
P[Y ≤ y,∆ = 1] = P[T ≤ y, T ≤ C] =
∫ y
0
f(u)G¯(u)du and
P[Y ≤ y,∆ = 0] = P[C ≤ y, C < T ] =
∫ y
0
g(u)F¯ (u)du.
Then, denoting θ = (α0, . . . , αK−1, β0, . . . , βK−1)> the parameters to infer and con-
sidering an independent and identically distributed (i.i.d.) cohort of n patients
(x1, y1, δ1), . . . , (xn, yn, δn) ∈ Rd×R+×{0, 1}, the log-likelihood of the C-mix model
can be written
`n(θ) = `n(θ ;y, δ) = n
−1
n∑
i=1
{
δi log
[
G¯(y−i )
K−1∑
k=0
piβk(xi)fk(yi;αk)
]
+(1− δi) log
[
g(yi)
K−1∑
k=0
piβk(xi)F¯k(y
−
i ;αk)
]}
,
where we use the notations y = (y1, . . . , yn)
> and δ = (δ1, . . . , δn)>. Note that from
now on, all computations are done conditionally on the covariates (xi)i=1,...,n. An
important fact is that we do not need to know or parametrize G¯ nor g, namely the
distribution of the censoring, for inference in this model (since all G¯ and g terms
vanish in Equation (6)).
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3 Inference of C-mix
In this section, we describe the procedure for estimating the parameters of the C-
mix model. We begin by presenting the Quasi-Newton Expectation Maximization
(QNEM) algorithm we use for inference. We then focus our study on the convergence
properties of the algorithm.
3.1 QNEM algorithm
In order to avoid overfitting and to improve the prediction power of our model, we
use Elastic-Net regularization [Zou and Hastie, 2005] by minimizing the penalized
objective
`penn (θ) = −`n(θ) +
K−1∑
k=0
γk
(
(1− η)‖βk‖1 + η
2
‖βk‖22
)
, (4)
where we add a linear combination of the lasso (`1) and ridge (squared `2) penal-
ties for a fixed η ∈ [0, 1], tuning parameter γk, and where we denote ‖βk‖p =(∑d
i=1 |βk,i|p
)1/p
the `p-norm of βk. One advantage of this regularization method
is its ability to perform model selection (the lasso part) and pinpoint the most
important covariates relatively to the prediction objective. On the other hand, the
ridge part allows to handle potential correlation between covariates [Zou and Hastie,
2005]. Note that in practice, the intercept is not regularized.
In order to derive an algorithm for this objective, we introduce a so-called Quasi-
Newton Expectation Maximization (QNEM), being a combination between an EM
algorithm [Dempster et al., 1977] and a L-BFGS-B algorithm [Zhu et al., 1997]. For
the EM part, we need to compute the negative completed log-likelihood (here scaled
by n−1), namely the negative joint distribution of y, δ and z = (z1, . . . , zn)>. It can
be written
`compn (θ) = `
comp
n (θ;y, δ, z)
= −n−1
n∑
i=1
{
δi
[K−1∑
k=0
1{zi=k}
(
log piβk(xi) + log fk(yi;αk)
)
+ log G¯(y−i )
]
+ (1− δi)
[K−1∑
k=0
1{zi=k}
(
log piβk(xi) + log F¯k(y
−
i ;αk)
)
+ log g(yi)
]}
.
(5)
Suppose that we are at step l + 1 of the algorithm, with current iterate denoted
θ(l) = (α
(l)
0 , . . . , α
(l)
K−1, β
(l)
0 , . . . , β
(l)
K−1)
>. For the E-step, we need to compute the
expected log-likelihood given by
Qn(θ, θ
(l)) = Eθ(l) [`compn (θ)|y, δ].
We note that
q
(l)
i,k = Eθ(l) [1{zi=k}|yi, δi] = Pθ(l) [zi = k|yi, δi] =
Λ
(l)
k,i∑K−1
r=0 Λ
(l)
r,i
(6)
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with
Λ
(l)
k,i =
[
fk(yi;α
(l)
k )G¯(y
−
i )
]δi[g(yi)F¯k(y−i ;α(l)k )]1−δipiβ(l)k (xi) (7)
so that Qn(θ, θ
(l)) is obtained from (5) by replacing the two 1{zi=k} occurrences with
q
(l)
i,k. Depending on the chosen distributions fk, the M-step can either be explicit for
the updates of αk (see Section 3.3 below for the geometric distributions case), or
obtained using a minimization algorithm otherwise.
Let us focus now on the update of βk in the M-step of the algorithm. By denoting
R
(l)
n,k(βk) = −n−1
n∑
i=1
q
(l)
i,k log piβk(xi)
the quantities involved in Qn that depend on βk, the update for βk therefore requires
to minimize
R
(l)
n,k(βk) + γk
(
(1− η)‖βk‖1 + η
2
‖βk‖22
)
. (8)
The minimization Problem (8) is a convex problem. It looks like the logistic regres-
sion objective, where labels are not fixed but softly encoded by the expectation step
(computation of q
(l)
i,k above, see Equation (6)).
We minimize (8) using the well-known L-BFGS-B algorithm [Zhu et al., 1997].
This algorithm belongs to the class of quasi-Newton optimization routines, which
solve the given minimization problem by computing approximations of the inverse
Hessian matrix of the objective function. It can deal with differentiable convex
objectives with box constraints. In order to use it with `1 penalization, which is
not differentiable, we use the trick borrowed from Andrew and Gao [2007]: for
a ∈ R, write |a| = a+ + a−, where a+ and a− are respectively the positive and
negative part of a, and add the constraints a+ ≥ 0 and a− ≥ 0. Namely, we
rewrite the minimization problem (8) as the following differentiable problem with
box constraints
minimize R
(l)
n,k(β
+
k − β−k ) + γk(1− η)
d∑
j=1
(β+k,j + β
−
k,j) + γk
η
2
‖β+k − β−k ‖22
subject to β+k,j ≥ 0 and β−k,j ≥ 0 for all j ∈ {1, . . . , d},
(9)
where β±k = (β
±
k,1, . . . , β
±
k,d)
>. The L-BFGS-B solver requires the exact value of the
gradient, which is easily given by
∂R
(l)
n,k(βk)
∂βk
= −n−1
n∑
i=1
q
(l)
i,k
(
1− piβk(xi)
)
xi. (10)
In Algorithm 1, we describe the main steps of the QNEM algorithm to minimize the
function given in Equation (4).
The penalization parameters γk are chosen using cross-validation, see Section A of
Appendices for precise statements about this procedure and about other numerical
details.
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Algorithm 1: QNEM Algorithm for inference of the C-mix model
Require: Training data (xi, yi, δi)i∈{1,...,n}; starting parameters
(α
(0)
k , β
(0)
k )k∈{0,...,K−1}; tuning parameters γk ≥ 0.
1: for l = 0, . . . , until convergence do
2: Compute (q
(l)
i,k)k∈{0,...,K−1} using Equation (6).
3: Compute (α
(l+1)
k )k∈{0,...,K−1}.
4: Compute (β
(l+1)
k )k∈{0,...,K−1} by solving (9) with the L-BFGS-B algorithm.
5: end for
6: return Last parameters (α
(l)
k , β
(l)
k )k∈{0,...,K−1}.
3.2 Convergence to a stationary point
We are addressing here convergence properties of the QNEM algorithm described in
Section 3.1 for the minimization of the objective function defined in Equation (4).
Let us denote
Qpenn (θ, θ
(l)) = Qn(θ, θ
(l)) +
K−1∑
k=0
γk
(
(1− η)‖βk‖1 + η
2
‖βk‖22
)
.
Convergence properties of the EM algorithm in a general setting are well known,
see Wu [1983]. In the QNEM algorithm, since we only improve Qpenn (θ, θ
(l)) instead
of a minimization of Qn(θ, θ
(l)), we are not in the EM algorithm setting but in a so
called generalized EM (GEM) algorithm setting [Dempster et al., 1977]. For such an
algorithm, we do have the descent property, in the sense that the criterion function
given in Equation (4) is reduced at each iteration, namely
`penn (θ
(l+1)) ≤ `penn (θ(l)).
Let us make two hypothesis.
Hypothesis 3 The duration densities fk are such that `
pen
n is bounded for all θ.
Hypothesis 4 Qpenn (θ, θ
(l)) is continuous in θ and θ(l), and for any fixed θ(l), Qpenn (θ, θ
(l))
is a convex function in θ and is strictly convex in each coordinate of θ.
Under Hypothesis 3, l 7→ `penn (θ(l)) decreases monotically to some finite limit. By
adding Hypothesis 4, convergence of the QNEM algorithm to a stationary point can
be shown. In particular, the stationary point is here a local minimum.
Theorem 1 Under Hypothesis 3 and 4, and considering the QNEM algorithm for
the criterion function defined in Equation (4), every cluster point θ¯ of the sequence
{θ(l); l = 0, 1, 2, . . . } generated by the QNEM algorithm is a stationary point of the
criterion function defined in Equation (4).
A proof is given in Section B of Appendices.
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3.3 Parameterization
Let us discuss here the parametrization choices we made in the experimental part.
First, in many applications - including the one addressed in Section 5 - we are
interested in identifying one subgroup of the population with a high risk of adverse
event compared to the others. Then, in the following, we consider Z ∈ {0, 1} where
Z = 1 means high-risk of early death and Z = 0 means low risk. Moreover, in such
a setting where K = 2, one can compare the learned groups by the C-mix and the
ones learned by the CURE model in terms of survival curves (see Figure 5).
To simplify notations and given the constraint formulated in Equation 2, we set
β0 = 0 and we denote β = β1 and piβ(x) the conditional probability that a patient
belongs to the group with high risk of death, given its covariates x.
In practice, we deal with discrete times in days. It turns out that the times of
the data used for applications in Section 5 is well fitted by Weibull distributions.
This choice of distribution is very popular in survival analysis, see for instance Klein
and Moeschberger [2005]. We then first derive the QNEM algorithm with
fk(t;αk) = (1− φk)tµk − (1− φk)(t+1)µk
with here αk = (φk, µk) ∈ (0, 1)×R+, φk being the scale parameter and µk the shape
parameter of the distribution.
As explained in the following Section 4, we select the best model using a cross-
validation procedure based on the C-index metric, and the performances are eval-
uated according to both C-index and AUC(t) metrics (see Sections 4.3 for de-
tails). Those two metrics have the following property: if we apply any mapping
on the marker vector (predicted on a test set) such that the order between all
vector coefficient values is conserved, then both C-index and AUC(t) estimates re-
main unchanged. In other words, by denoting (Mi)i∈{1,...,ntest} the vector of mark-
ers predicted on a test set of ntest individuals, if ψ is a function such that for all
(i, j) ∈ {1, . . . , ntest}2,
(
Mi < Mj ⇒ ψ(Mi) < ψ(Mj)
)
, then both C-index and
AUC(t) estimates induced by (Mi)i∈{1,...,ntest} or by
(
ψ(Mi)
)
i∈{1,...,ntest} are the same.
The order in the marker coefficients is actually paramount when the performances
are evaluated according to the mentioned metrics. Furthermore, it turns out that
empirically, if we add a constraint on the mixture of Weibull that enforces an order
like relation between the two distributions f0 and f1, the performances are improved.
To be more precise, the constraint to impose is that the two density curves do not
intersect. We then choose to impose the following: the two scale parameters are
equal, i.e. φ0 = φ1 = φ. Indeed under this hypothesis, we do have that for all
φ ∈ (0, 1), (µ0 < µ1 ⇒ ∀t ∈ R+, f0(t;α0) > f1(t;α1)).
With this Weibull parameterization, updates for αk are not explicit in the QNEM
algorithm, and consequently require some iterations of a minimization algorithm.
Seeking to have explicit updates for αk, we then derive the algorithm with geometric
distributions instead of Weibull (geometric being a particular case of Weibull with
µk = 1), namely fk(t;αk) = αk(1− αk)t−1 with αk ∈ (0, 1).
With this parameterization, we obtain from Equation (7)
Λ
(l)
1,i =
[
α
(l)
1 (1− α(l)1 )yi−1
]δi[(1− α(l)1 )yi]1−δipiβ(l)(xi) and
Λ
(l)
0,i =
[
α
(l)
0 (1− α(l)0 )yi−1
]δi[(1− α(l)0 )yi]1−δi(1− piβ(l)(xi)),
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which leads to the following explicit M-step
α
(l+1)
0 =
∑n
i=1 δi(1− q(l)i )∑n
i=1(1− q(l)i )yi
and α
(l+1)
1 =
∑n
i=1 δiq
(l)
i∑n
i=1 q
(l)
i yi
.
In this setting, implementation is hence straightforward. Note that Hypothesis 3
and 4 are immediately satisfied with this geometric parameterization.
In Section 5, we note that performances are similar for the C-mix model with
Weibull or geometric distributions on all considered biomedical datasets. The geo-
metric parameterization leading to more straightforward computations, it is the one
used to parameterize the C-mix model in what follows, if not otherwise stated. Let
us focus now on the performance evaluation of the C-mix model and its comparison
with the Cox PH and CURE models, both regularized with the Elastic-Net.
4 Performance evaluation
In this section, we first briefly introduce the models we consider for performance
comparisons. Then, we provide details regarding the simulation study and data
generation. The chosen metrics for evaluating performances are then presented,
followed by the results.
4.1 Competing models
The first model we consider is the Cox PH model penalized by the Elastic-Net,
denoted Cox PH in the following. In this model introduced in Cox [1972], the
partial log-likelihood is given by
`coxn (β) = n
−1
n∑
i=1
δi
(
x>i β − log
∑
i′:yi′≥yi
exp(x>i′ β)
)
.
We use respectively the R packages survival and glmnet [Simon et al., 2011] for
the partial log-likelihood and the minimization of the following quantity
−`coxn (β) + γ
(
(1− η)‖β‖1 + η
2
‖β‖22
)
,
where γ is chosen by the same cross-validation procedure than the C-mix model,
for a given η (see Section A of Appendices. Ties are handled via the Breslow
approximation of the partial likelihood [Breslow, 1972].
We remark that the model introduced in this paper cannot be reduced to a Cox
model. Indeed, the C-mix model intensity can be written (in the geometric case)
λ(t) =
α1(1− α1)t−1 + α0(1− α0)t−1 exp(x>β)
(1− α1)t + (1− α0)t exp(x>β) ,
while it is given by Equation (1) in the Cox model.
Finally, we consider the CURE Farewell [1982] model penalized by the Elastic-
Net and denoted CURE in the following, with a logistic function for the incidence
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part and a parametric survival model for S(t|Z = 1), where Z = 0 means that
patient is cured, Z = 1 means that patient is not cured, and S(t) = exp(− ∫ t
0
λ(s)ds)
denotes the survival function. In this model, we then have S(t|Z = 0) constant
and equal to 1. We add an Elastic-Net regularization term, and since we were
not able to find any open source package where CURE models were implemented
with a regularized objective, we used the QNEM algorithm in the particular case
of CURE model. We just add the constraint that the geometric distribution G(α0)
corresponding to the cured group of patients (Z = 0) has a parameter α0 = 0, which
does not change over the algorithm iterations. The QNEM algorithm can be used
in this particular case, were some terms have disapeared from the completed log-
likelihood, since in the CURE model case we have
{
i ∈ {1, . . . , n} : zi = 0, δi = 1
}
=
∅. Note that in the original introduction of the CURE model in Farewell [1982], the
density of uncured patients directly depends on individual patient covariates, which
is not the case here.
We also give additional simulation settings in Section C of Appendices. First,
the case where d  n, including a comparison of the screening strategy we use in
Section 5 with the iterative sure independence screening [Fan et al., 2010] (ISIS)
method. We also add simulations where data is generated according to the C-
mix model with gamma distributions instead of geometric ones, and include the
accelerated failure time model [Wei, 1992] (AFT) in the performances comparison
study.
4.2 Simulation design
In order to assess the proposed method, we perform an extensive Monte Carlo
simulation study. Since we want to compare the performances of the 3 models
mentioned above, we consider 3 simulation cases for the time distribution: one for
each competing model. We first choose a coefficient vector β = (ν, . . . , ν︸ ︷︷ ︸
s
, 0, . . . , 0) ∈
Rd, with ν ∈ R being the value of the active coefficients and s ∈ {1, . . . , d} a sparsity
parameter. For a desired low-risk patients proportion pi0 ∈ [0, 1], the high-risk
patients index set is given by
H = {b(1− pi0)× nc random samples without replacement} ⊂ {1, . . . , n},
where bac denotes the largest integer less than or equal to a ∈ R. For the generation
of the covariates matrix, we first take [xij] ∈ Rn×d ∼ N (0,Σ(ρ)), with Σ(ρ) a (d×d)
Toeplitz covariance matrix [Mukherjee and Maiti, 1988] with correlation ρ ∈ (0, 1).
We then add a gap ∈ R+ value for patients i ∈ H and subtract it for patients i /∈ H,
only on active covariates plus a proportion rcf ∈ [0, 1] of the non-active covariates
considered as confusion factors, that is
xij ← xij ± gap for j ∈
{
1, . . . , s, . . . , b(d− s)rcfc
}
.
Note that this is equivalent to generate the covariates according to a gaussian mix-
ture.
Then we generate Zi ∼ B
(
piβ(xi)
)
in the C-mix or CURE simulation case,
where piβ(xi) is computed given Equation (3), with geometric distributions for
10
the durations (see Section 3.3). We obtain Ti ∼ G(αZi) in the C-mix case, and
Ti ∼ ∞1{Zi=0} + G(α1)1{Zi=1} in the CURE case. For the Cox PH model, we take
Ti ∼ − log(Ui) exp(−x>i β), with Ui ∼ U([0, 1]) and where U([a, b]) stands for the
uniform distribution on a segment [a, b].
The distribution of the censoring variable Ci is geometric G(αc), with αc ∈ (0, 1).
The parameter αc is tuned to maintain a desired censoring rate rc ∈ [0, 1], using a
formula given in Section D of Appendices. The values of the chosen hyper parameters
are sumarized in Table 6.
Table 1: Hyper-parameters choice for simulation
η n d s rcf ν ρ pi0 gap rc α0 α1
0.1 100, 200, 500 30, 100 10 0.3 1 0.5 0.75 0.1, 0.3, 1 0.2, 0.5 0.01 0.5
Note that when simulating under the CURE model, the proportion of censored time
events is at least equal to pi0 : we then choose pi0 = 0.2 for the CURE simulations
only.
Finally, we want to assess the stability of the C-mix model in terms of variable
selection and compare it to the CURE and Cox PH models. To this end, we follow
the same simulation procedure explained in the previous lines. For each simulation
case, we make vary the two hyper-parameters that impact the most the stability
of the variable selection, that is the gap varying in [0, 2] and the confusion rate rcf
varying in [0, 1]. All other hyper-parameters are the same than in Table 6, except
s = 150 and with the choice (n, d) = (200, 300). For a given hyper-parameters
configuration (gap, rcf ), we use the following approach to evaluate the variable
selection power of the models. Denoting β˜i = |βˆi|/max
{|βˆi|, i ∈ {1, . . . , d}}, if we
consider that β˜i is the predicted probability that the true βi equals ν, then we are in
a binary prediction setting and we use the resulting AUC of this problem. Explicit
examples of such AUC computations are given in Section E of Appendices.
4.3 Metrics
We detail in this section the metrics considered to evaluate risk prediction perfor-
mances. Let us denote by M the marker under study. Note that M = piβˆ(X) in the
C-mix and the CURE model cases, and M = exp(X>βˆcox) in the Cox PH model
case. We denote by h the probability density function of marker M , and assume
that the marker is measured once at t = 0.
For any threshold ξ, cumulative true positive rates and dynamic false positive
rates are two functions of time respectively defined as TPRC(ξ, t) = P[M > ξ|T ≤ t]
and FPRD(ξ, t) = P[M > ξ|T > t]. Then, as introduced in Heagerty et al. [2000],
the cumulative dynamic time-dependent AUC is defined as follows
AUCC,D(t) =
∫ ∞
−∞
TPRC(ξ, t)
∣∣∣∣∂FPRD(ξ, t)∂ξ
∣∣∣∣ dξ,
that we simply denote AUC(t) in the following. We use the Inverse Probability of
Censoring Weighting (IPCW) estimate of this quantity with a Kaplan-Meier esti-
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mator of the conditional survival function P[T > t|M = m], as proposed in Blanche
et al. [2013] and already implemented in the R package timeROC.
A common concordance measure that does not depend on time is the C-index [Har-
rell et al., 1996] defined by
C = P[Mi > Mj|Ti < Tj],
with i 6= j two independent patients (which does not depend on i, j under the
i.i.d. sample hypothesis). In our case, T is subject to right censoring, so one would
typically consider the modified Cτ defined by
Cτ = P[Mi > Mj|Yi < Yj, Yi < τ ],
with τ corresponding to the fixed and prespecified follow-up period duration [Hea-
gerty and Zheng, 2005]. A Kaplan-Meier estimator for the censoring distribution
leads to a nonparametric and consistent estimator of Cτ [Uno et al., 2011], already
implemented in the R package survival.
Hence in the following, we consider both AUC(t) and C-index metrics to assess
performances.
4.4 Results of simulation
We present now the simulation results concerning the C-index metric in the case
(d, rc) = (30, 0.5) in Table 2. See Section F of Appendices for results on other
configurations for (d, rc). Each value is obtained by computing the C-index average
and standard deviation (in parenthesis) over 100 simulations. The AUC(t) average
(bold line) and standard deviation (bands) over the same 100 simulations are then
given in Figure 1, where n = 100. Note that the value of the gap can be viewed as
a difficulty level of the problem, since the higher the value of the gap, the clearer
the separation between the two populations (low risk and high risk patients).
The results measured both by AUC(t) and C-index lead to the same conclu-
sion: the C-mix model almost always leads to the best results, even under model
misspecification, i.e. when data is generated according to the CURE or Cox PH
model. Namely, under CURE simulations, C-mix and CURE give very close results,
with a strong improvement over Cox PH. Under Cox PH and C-mix simulations,
C-mix outperforms both Cox PH and CURE. Surprisingly enough, this exhibits a
strong generalization property of the C-mix model, over both Cox PH and CURE.
Note that this phenomenon is particularly strong for small gap values, while with
an increasing gap (or an increasing sample size n), all procedures barely exhibit the
same performance. It can be first explained by the non parametric baseline function
in the Cox PH model, and second by the fact that unlike the Cox PH model, the
C-mix and CURE models exploit directly the mixture aspect.
Finally, Figure 2 gives the results concerning the stability of the variable selection
aspect of the competing models. The C-mix model appears to be the best method
as well considering the variable selection aspect, even under model misspecification.
We notice a general behaviour of our method that we describe in the following,
which is also shared by the CURE model only when the data is simulated according
to itself, and which justifies the log scale for the gap to clearly distinguish the three
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following phases. For very small gap values (less than 0.2), the confusion rate rcf
does not impact the variable selection performances, since adding very small gap
values to the covariates is almost imperceptible. This means that the resulting
AUC is the same when there is no confusion factors and when rcf = 1 (that is when
there are half active covariates and half confusion ones). For medium gap values
(saying between 0.2 and 1), the confusion factors are more difficult to identify by
the model as there number goes up (that is when rcf increases), which is precisely
the confusion factors effect we expect to observe. Then, for large gap values (more
than 1), the model succeeds in vanishing properly all confusion factors since the two
subpopulations are more clearly separated regarding the covariates, and the problem
becomes naturally easier as the gap increases.
5 Application to genetic data
In this section, we apply our method on three genetic datasets and compare its
performance to the Cox PH and CURE models. We extracted normalized expression
data and survival times Y in days from breast invasive carcinoma (BRCA, n = 1211),
glioblastoma multiforme (GBM, n = 168) and kidney renal clear cell carcinoma
(KIRC, n = 605).
These datasets are available on The Cancer Genome Atlas (TCGA) platform,
which aims at accelerating the understanding of the molecular basis of cancer through
the application of genomic technologies, including large-scale genome sequencing.
For each patient, 20531 covariates corresponding to the normalized gene expressions
are available. We randomly split all datasets into a training set and a test set (30%
for testing, cross-validation is done on the training).
We compare the three models both in terms of C-index and AUC(t) on the test
sets. Inference of the Cox PH model fails in very high dimension on the considered
data with the glmnet package. We therefore make a first variable selection (screen-
ing) among the 20531 covariates. To do so, we compute the C-index obtained by
univariate Cox PH models (not to confer advantage to our method), namely Cox
PH models fitted on each covariate separately. We then ordered the obtained 20531
C-indexes by decreasing order and extracted the top d = 100, d = 300 and d = 1000
covariates. We then apply the three methods on the obtained covariates.
The results in terms of AUC(t) curves are given in Figure 3 for d = 300, where
we distinguish the C-mix model with geometric or Weibull distributions.
Then it appears that the performances are very close in terms of AUC(t) between
the C-mix model with geometric or Weibull distributions, which is also validated if
we compare the corresponding C-index for these two parameterizations in Table 3.
Similar conclusions in terms of C-index, AUC(t) and computing time can be
made on all considered datasets and for any choice of d. Hence, as already men-
tionned in Section 3.3, we only concentrate on the geometric parameterization for
the C-mix model. The results in terms of C-index are then given in Table 4.
A more direct approach to compare performances between models, rather than
only focus on the marker order aspect, is to predict the survival of patients in
the test set within a specified short time. For the Cox PH model, the survival
13
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Figure 1: Average (bold lines) and standard deviation (bands) for AUC(t) on 100
simulated data with n = 100, d = 30 and rc = 0.5. Rows correspond to the
model simulated (cf. Section 4.2) while columns correspond to different gap values
(the problem becomes more difficult as the gap value decreases). Surprisingly, our
method gives almost always the best results, even under model misspecification (see
Cox PH and CURE simulation cases on the second and third rows).
Table 3: C-index comparison between geometric or Weibull parameterizations for
the C-mix model on the three TCGA data sets considered (with d = 300). In all
cases, results are very similar for the two distribution choices.
Parameterization Geometric Weibull
BRCA 0.782 0.780
Cancer GBM 0.755 0.754
KIRC 0.849 0.835
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Figure 2: Average AUC calculated according to Section 4.2 and obtained after 100
simulated data for each (gap, rcf ) configuration (a grid of 20x20 different configu-
rations is considered). A gaussian interpolation is then performed to obtain smooth
figures. Note that the gap values are log-scaled. Rows correspond to the model
simulated while columns correspond to the model under consideration for the vari-
able selection evaluation procedure. Our method gives the best results in terms of
variable selection, even under model misspecification.
P[Ti > t|Xi = xi] for patient i in the test set is estimated by
Sˆi(t|Xi = xi) = [Sˆcox0 (t)]exp(x
>
i βˆ
cox),
where Sˆcox0 is the estimated survival function of baseline population (x = 0) obtained
using the Breslow estimate of λ0 [Breslow, 1972]. For the CURE or the C-mix
models, it is naturally estimated by
Sˆi(t|Xi = xi) = piβˆ(xi)Sˆ1(t) +
(
1− piβˆ(xi)
)
Sˆ0(t),
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(a) BRCA (b) GBM (c) KIRC
Figure 3: AUC(t) comparison on the three TCGA data sets considered, for d =
300. We observe that C-mix model leads to the best results (higher is better) and
outperforms both Cox PH and CURE in all cases. Results are similar in terms of
performances for the C-mix model with geometric or Weibull distributions.
Table 4: C-index comparison on the three TCGA data sets considered. In all cases,
C-mix gives the best results (in bold).
Cancer BRCA GBM KIRC
Model C-mix CURE Cox PH C-mix CURE Cox PH C-mix CURE Cox PH
100 0.792 0.764 0.705 0.826 0.695 0.571 0.768 0.732 0.716
d 300 0.782 0.753 0.723 0.849 0.697 0.571 0.755 0.691 0.698
1000 0.817 0.613 0.577 0.775 0.699 0.592 0.743 0.690 0.685
where Sˆ0 and Sˆ1 are the Kaplan-Meier estimators [Kaplan and Meier, 1958] of the
low and high risk subgroups respectively, learned by the C-mix or CURE models
(patients with piβˆ(xi) > 0.5 are clustered in the high risk subgroup, others in the
low risk one). The corresponding estimated survival curves are given in Figure 4.
We observe that the subgroups obtained by the C-mix are more clearly separated
in terms of survival than those obtained by the CURE model.
For a given time , one can now use Sˆi(|Xi = xi) for each model to predict
whether or not Ti >  on the test set, resulting on a binary classification problem
that we assess using the classical AUC score. By moving  within the first years of
follow-up, since it is the more interesting for physicians in practice, one obtains the
curves given in Figure 5.
Let us now focus on the runtime comparison between the models in Table 5. We
choose the BRCA dataset to illustrate this point, since it is the larger one (n = 1211)
and consequently provides more clearer time-consuming differences.
We also notice that despite using the same QNEM algorithm steps, our CURE model
implementation is slower since convergence takes more time to be reached, as shows
Figure 6.
In Section G of Appendices, the top 20 selected genes for each cancer type and
for all models are presented (for d = 300). Literature on those genes is mined to
estimate two simple scores that provide information about how related they are to
cancer in general first, and second to cancer plus the survival aspect, according to
scientific publications. It turns out that some genes have been widely studied in the
literature (e.g. FLT3 for the GBM cancer), while for others, very few publications
were retrieved (e.g. TRMT2B still for the GBM cancer).
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Figure 4: Estimated survival curves per subgroups (blue for low risk and red for
high risk) with the corresponding 95 % confidence bands for the C-mix and CURE
models: BRCA in column (a), GBM in column (b) and KIRC in column (c).
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Figure 5: Comparison of the survival prediction performances between models on
the three TCGA data sets considered (still with d = 300). Performances are, onces
again, much better for the C-mix over the two other standard methods.
Table 5: Computing time comparison in second on the BRCA dataset (n = 1211),
with corresponding C-index in parenthesis and best result in bold in each case.
This times concern the learning task for each model with the best hyper parameter
selected after the cross validation procedure. It turns out that our method is by far
the fastest in addition to providing the best performances. In particular, the QNEM
algorithm is faster than the R implementation glmnet.
Model C-mix CURE Cox PH
100 0.025 (0.792) 1.992 (0.764) 0.446 (0.705)
d 300 0.027 (0.782) 2.343 (0.753) 0.810 (0.723)
1000 0.139 (0.817) 12.067 (0.613) 2.145 (0.577)
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Figure 6: Convergence comparison between C-mix and CURE models through the
QNEM algorithm. The relative objective is here defined at iteration l as
(
`penn (θ
(l))−
`penn (θˆ)
)
/`penn (θˆ), where θˆ is naturally the parameter vector returned at the end of
the QNEM algorithm, that is once convergence is reached. Note that both iteration
and relative objective axis are log-scaled for clarity. We observe that convergence
for the C-mix model is dramaticaly faster than the CURE one.
6 Concluding remarks
In this paper, a mixture model for censored durations (C-mix) has been introduced,
and a new efficient estimation algorithm (QNEM) has been derived, that considers
a penalization of the likelihood in order to perform covariate selection and to pre-
vent overfitting. A strong improvement is provided over the CURE and Cox PH
approches (both penalized by the Elastic-Net), which are, by far, the most widely
used for biomedical data analysis. But more importantly, our method detects rele-
vant subgroups of patients regarding their risk in a supervised learning procedure,
and takes advantage of this identification to improve survival prediction over more
standard methods. An extensive Monte Carlo simulation study has been carried out
to evaluate the performance of the developed estimation procedure. It showed that
our approach is robust to model misspecification. The proposed methodology has
then been applied on three high dimensional datasets. On these datasets, C-mix
outperforms both Cox PH and CURE, in terms of AUC(t), C-index or survival pre-
diction. Moreover, many gene expressions pinpointed by the feature selection aspect
of our regularized method are relevant for medical interpretations (e.g. NFKBIA,
LEF1, SUSD3 or FAIM3 for the BRCA cancer, see Zhou et al. [2007] or Oskars-
son et al. [2011]), whilst others must involve further investigations in the genetic
research community. Finally, our analysis provides, as a by-product, a new robust
implementation of CURE models in high dimension.
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Software
All the methodology discussed in this paper is implemented in Python. The code
is available from https://github.com/SimonBussy/C-mix in the form of annotated
programs, together with a notebook tutorial.
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Appendices
A Numerical details
Let us first give some details about the starting point of Algorithm 1. For all
k ∈ {0, . . . , K − 1}, we simply use β(0)k as the zero vector, and for α(0)k we fit a
censored parametric mixture model on (yi)i=1,...,n with an EM algorithm.
Concerning the V-fold cross validation procedure for tuning γk, we use V = 5 and
the cross-validation metric is the C-index. Let us precise that we choose γk as the
largest value such that error is within one standard error of the minimum, and that
a grid-search is made during the cross-validation on an interval [γmaxk × 10−4, γmaxk ],
with γmaxk the interval upper bound computed in the following.
Let us consider the following convex minimization problem resulting from Equa-
tion (8), at a given step l:
βˆk ∈ argmin
β∈Rd
R
(l)
n,k(β) + γk
(
(1− η)‖β‖1 + η
2
‖β‖22
)
.
Regarding the grid of candidate values for γk, we consider γ
1
k ≤ γ2k ≤ · · · ≤ γmaxk . At
γmaxk , all coefficients βˆk,j for j ∈ {1, . . . , d} are exactly zero. The KKT conditions
[Boyd and Vandenberghe, 2004] claim that
∂R
(l)
n,k(βˆk)
∂βj
= γk(1− η) sgn(βˆk,j) + ηβˆk,j ∀j ∈ Aˆk∣∣∣∣∣∂R
(l)
n,k(βˆk)
∂βj
∣∣∣∣∣ < γk(1− η) ∀j /∈ Aˆk
,
where Aˆk =
{
j ∈ {1, . . . , d} : βˆk,j 6= 0
}
is the active set of the βˆk estimator, and for
all x ∈ R \ {0}, sgn(x) = 1{x>0} − 1{x<0}. Then, using (10), one obtains
∀j ∈ {1, . . . , d}, βˆk,j = 0⇒ ∀j ∈ {1, . . . , d},
∣∣∣∣∣n−1
n∑
i=1
q
(l)
i,k
1
2
xij
∣∣∣∣∣ < γk(1− η)
20
Hence, we choose the following upper bound for the grid search interval during the
cross-validation procedure
γmaxk =
1
2n(1− η) maxj∈{1,...,d}
n∑
i=1
|xij|.
B Proof of Theorem 1
Let us denote D =
∑K−1
k=0 dk + Kd the number of coordinates of θ so that one can
write
θ = (θ1, . . . , θD) = (α0, . . . , αK−1, β0, . . . , βK−1)> ∈ Θ ⊂ RD.
We denote θ¯ a cluster point of the sequence S = {θ(l); l = 0, 1, 2, . . . } generated
by the QNEM algorithm, i.e. ∀ε > 0, Vε(θ¯) ∩ S \ {θ¯} 6= ∅, with Vε(θ¯) the epsilon-
neighbourhood of θ¯. We want to prove that θ¯ is a stationary point of the non-
differentiable function θ 7→ `penn (θ), which means [Tseng, 2001]:
∀r ∈ RD, νpen ′n (θ¯; r) = lim
ζ→0
`penn (θ¯ + rζ)− `penn (θ¯)
ζ
≥ 0. (11)
The proof is inspired by Bertsekas [1995]. The conditional density of the complete
data given the observed data can be written
k(θ) =
exp
(
`compn (θ)
)
exp
(
`n(θ)
) .
Then, one has
`penn (θ) = Q
pen
n (θ, θ
(l))−H(θ, θ(l)), (12)
where we introduced H(θ, θ(l)) = Eθ(l) [log
(
k(θ)
)
]. The key argument relies on the
following facts that hold under Hypothesis (3) and (4):
• Qpenn (θ, θ(l)) is continuous in θ and θ(l),
• for any fixed θ(l) (at the (l+1)-th M step of the algorithm), Qpen
n,θ(l)
(θ) is convex
in θ and strictly convex in each coordinate of θ.
Let r ∈ RD be an arbitrary direction, then Equations (11) and (12) yield
`pen
′
n (θ¯; r) = Q
pen ′
n,θ¯
(θ¯; r)− 〈5Hθ¯(θ¯), r〉.
Hence, by Jensen’s inequality we get
∀θ ∈ Θ, H(θ(l), θ(l)) ≤ H(θ, θ(l)), (13)
and so θ 7→ Hθ¯(θ) is minimized for θ = θ(l), then we have 5Hθ¯(θ¯) = 0. It remains
to prove that Qpen
′
n,θ¯
(θ¯; r) ≥ 0. Let us focus on the proof of the following expression
∀x1, Qpenn,θ¯ (θ¯) ≤ Qpenn,θ¯ (x1, θ¯2, . . . , θ¯D). (14)
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Denoting w
(l)
i = (θ
(l+1)
1 , . . . , θ
(l+1)
i , θ
(l)
i+1, . . . , θ
(l)
D ) and from the definition of the QNEM
algorithm, we first have
Qpen
n,θ(l)
(θ(l)) ≥ Qpen
n,θ(l)
(w
(l)
1 ) ≥ · · · ≥ Qpenn,θ(l)(w
(l)
D−1) ≥ Qpenn,θ(l)(θ(l+1)), (15)
and second for all x1, Q
pen
n,θ(l)
(w
(l)
1 ) ≤ Qpenn,θ(l)(x1, θ
(l)
2 , . . . , θ
(l)
D ). Consequently, if (w
(l)
1 )l∈N
converges to θ¯, one obtains (14) by continuity taking the limit l → ∞. Let us now
suppose that (w
(l)
1 )l∈N does not converge to θ¯, so that (w
(l)
1 −θ(l))l∈N does not converge
to 0. Or equivalently: there exists a subsequence (w
(lj)
1 − θ(lj))j∈N not converging to
0.
Then, denoting ψ(lj) = ‖w(lj)1 − θ(lj)‖2, we may assume that there exists ψ¯ > 0
such that ∀j ∈ N, ψ(lj) > ψ¯ by removing from the subsequence (w(lj)1 − θ(lj))j∈N
any terms for which ψ(lj) = 0. Let s
(lj)
1 =
w
(lj)
1 −θ(lj)
ψ(lj)
, so that (s
(lj)
1 )j∈N belongs to a
compact set (‖s(lj)1 ‖ = 1) and then converges to s¯1 6= 0. Let us fix some  ∈ [0, 1],
then 0 ≤ ψ¯ ≤ ψ(lj). Moreover, θ(lj) + ψ¯s(lj)1 lies on the segment joining θ(lj) and
w
(lj)
1 , and consequently belongs to Θ since Θ is convex. As Q
pen
n,θ(lj)
(.) is convex
and w
(lj)
1 minimizes this function over all values that differ from θ
(lj) along the first
coordinate, one has
Qpen
n,θ(lj)
(w
(lj)
1 ) = Q
pen
n,θ(lj)
(θ(lj) + ψ(lj)s
(lj)
1 )
≤ Qpen
n,θ(lj)
(θ(lj) + ψ¯s
(lj)
1 )
≤ Qpen
n,θ(lj)
(θ(lj)). (16)
We finally obtain
0 ≤ Qpen
n,θ(lj)
(θ(lj))−Qpen
n,θ(lj)
(θ(lj) + ψ¯s
(lj)
1 )
≤
(16)
Qpen
n,θ(lj)
(θ(lj))−Qpen
n,θ(lj)
(w
(lj)
1 )
≤
(15)
Qpen
n,θ(lj)
(θ(lj))−Qpen
n,θ(lj)
(θ(lj+1))
≤
(12)
`penn (θ
(lj))− `penn (θ(lj+1)) +Hθ(lj)(θ(lj))−Hθ(lj)(θ(lj+1))︸ ︷︷ ︸
≤
(13)
0
≤ `penn (θ(lj))− `penn (θ(lj+1)) −→
j→∞
`penn (θ¯)− `penn (θ¯) = 0
By continuity of the function Qpenn (x, y) in both x and y and taking the limit j →
∞, we conclude that ∀ ∈ [0, 1], Qpen
n,θ¯
(θ¯ + ψ¯s¯1) = Q
pen
n,θ¯
(θ¯). Since ψ¯s¯1 6= 0, this
contradicts the strict convexity of x1 7→ Qpenn,θ(l)(x1, θ
(l)
2 , . . . , θ
(l)
D ) and establishes that
(w
(l)
1 )l∈N converges to θ¯.
Hence (14) is proved. Repeating the argument to each coordinate, we deduce that
θ¯ is a coordinate-wise minimum, and finally conclude that `pen
′
n (θ¯; r) ≥ 0 [Tseng,
2001]. Thus, θ¯ is a stationary point of the criterion function defined in Equation
(4).

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C Additional comparisons
In this section, we consider two extra simulation settings. First, we consider the case
d  n, which is the setting of our application on TCGA datasets. Then, we add
another simulation case under the C-mix model using gamma distributions instead
of geometric ones. The shared parameters in the two cases are given in Table 6.
Table 6: Hyper-parameters choice for simulation.
η n s rcf ν ρ pi0 gap rc
0.1 250 50 0.5 1 0.5 0.75 0.1 0.5
C.1 Case d n
Data is here generated under the C-mix model with (α0, α1) = (0.1, 0.5) and d ∈
{200, 500, 1000}. The 3 models are trained on a training set and risk prediction is
made on a test set. We also compare the 3 models when a dimension reduction step
is performed at first, using two different screening methods. The first is based on
univariate Cox PH models, namely the one we used in Section 5 of the paper (in
our application to genetic data), where we select here the top 100 variables. This
screening method is hence referred as “top 100” in the following. The second is the
iterative sure independence screening (ISIS) method introduced in Fan et al. [2010],
using the R package SIS Saldana and Feng [2016]. Prediction performances are
compared in terms of C-index, while variable selection performances are compared
in terms of AUC using the method detailed in Section E, and we also add two more
classical scores [Fan et al., 2010] for comparison: the median `1 and squared `2
estimation errors, given by ‖β− βˆ‖1 and ‖β− βˆ‖2 respectively. Results are given in
Table 7.
The C-mix model obtains constantly the best C-index performances in predic-
tion, for all settings. Moreover, the “top 100” screening method improve the 3
models prediction power, while ISIS method only improve the Cox PH model pre-
diction power. As expected, ISIS method significantly improve the Cox PH model
in terms of variable selection and obtains the best results for d = 500 and 1000.
Conclusions in terms of variable selection are the same relatively to the AUC, `1
and squared `2 estimation errors. Then, in the paper, we only focus on the AUC
method detailed in Section E. Note that the Cox PH model obtains the best results
in terms of variable selection with the two screening method, since both screening
methods are based on the Cox PH model. Thus, one could improve the C-mix
variable selection performances by simply use the “top 100” screening method with
univariate C-mix, which was not the purpose of the section. Finally, the results
obtained justify the screening strategy we use in Section 5 of the paper.
C.2 Case of times simulated with a mixture of gammas
We consider here the case where data is simulated under the C-mix model with
gamma distributions instead of geometric ones, not to confer to the C-mix prior
23
Table 7: Average performances and standard deviation (in parenthesis) on 100 sim-
ulated data for different dimension d and different screening method (including no
screening). For each configuration, the best result appears in bold.
d screening model C-index AUC ‖β − βˆ‖1 ‖β − βˆ‖2
C-mix 0.716 (0.062) 0.653 (0.053) 51.540 (0.976) 7.254 (0.129)
none CURE 0.701 (0.067) 0.625 (0.052) 51.615 (1.275) 7.274 (0.122)
Cox PH 0.672 (0.089) 0.608 (0.063) 199.321 (0.490) 99.679 (0.229)
C-mix 0.737 (0.057) 0.682 (0.060) 52.297 (1.351) 7.381 (0.161)
200 top 100 CURE 0.714 (0.060) 0.651 (0.050) 52.366 (1.382) 7.386 (0.134)
Cox PH 0.692 (0.089) 0.630 (0.070) 52.747 (0.530) 7.946 (0.093)
C-mix 0.691 (0.049) 0.570 (0.011) 55.493 (1.624) 8.083 (0.394)
ISIS CURE 0.685 (0.050) 0.571 (0.009) 54.461 (1.112) 7.848 (0.211)
Cox PH 0.690 (0.049) 0.573 (0.011) 48.186 (0.366) 6.840 (0.037)
C-mix 0.710 (0.058) 0.642 (0.057) 51.627 (0.994) 7.277 (0.106)
none CURE 0.675 (0.057) 0.610 (0.052) 51.920 (2.411) 7.252 (0.138)
Cox PH 0.624 (0.097) 0.567 (0.057) 499.610 (0.396) 157.997 (0.117)
C-mix 0.735 (0.050) 0.694 (0.057) 53.161 (1.708) 7.433 (0.152)
500 top 100 CURE 0.703 (0.054) 0.649 (0.042) 53.419 (1.818) 7.387 (0.133)
Cox PH 0.682 (0.087) 0.633 (0.074) 49.465 (0.428) 6.937 (0.094)
C-mix 0.677 (0.051) 0.559 (0.013) 55.229 (1.831) 7.974 (0.375)
ISIS CURE 0.671 (0.051) 0.559 (0.015) 54.187 (1.244) 7.754 (0.227)
Cox PH 0.675 (0.051) 0.560 (0.016) 48.574 (0.614) 6.870 (0.054)
C-mix 0.694 (0.063) 0.633 (0.066) 51.976 (1.921) 7.272 (0.141)
none CURE 0.657 (0.067) 0.598 (0.057) 52.078 (2.414) 7.236 (0.138)
Cox PH 0.579 (0.092) 0.541 (0.050) 999.768 (0.316) 223.558 (0.067)
C-mix 0.726 (0.050) 0.693 (0.040) 53.813 (1.592) 7.149 (0.115)
1000 top 100 CURE 0.685 (0.061) 0.653 (0.037) 54.146 (1.596) 7.383 (0.090)
Cox PH 0.688 (0.076) 0.668 (0.064) 52.838 (0.558) 6.909 (0.077)
C-mix 0.653 (0.062) 0.553 (0.017) 53.760 (1.949) 7.269 (0.395)
ISIS CURE 0.652 (0.061) 0.554 (0.015) 53.928 (1.288) 7.687 (0.236)
Cox PH 0.652 (0.063) 0.553 (0.015) 51.826 (0.606) 6.895 (0.054)
information on the underlying survival distributions. Hence, one has
fk(t; ιk, ζk) =
tιk−1e−
t
ζk
ζ ιkk Γ(ιk)
,
with ιk the shape parameter, ζk the scale parameter and Γ the gamma function.
For the simulations, we choose (ι0, ζ0) = (5, 3) and (ι1, ζ1) = (1.5, 1), so that density
and survival curves are comparable with those in Section C.1, as illustrates Figure 7
below.
We also add another class of model for comparison in this context: the accel-
erated failure time model [Wei, 1992] (AFT); which can be viewed as a parametric
Cox model. Indeed, the semi-parametric property of the Cox PH model could lower
its performances compared to completely parametric models such as C-mix and
CURE ones, especially in simulations where n is relatively small. We use the R
package AdapEnetClass that implements AFT in a high dimensional setting us-
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Figure 7: Comparison of the density and survival curves of geometrics laws used in
Section C.1 and those used in this section. The supports are then relatively close.
ing two Elastic-Net regularization approaches [Khan and Shaw, 2016]: the adaptive
Elastic-Net (denoted AEnet in the following) and the weighted Elastic-Net (denoted
WEnet in the following). Results are given in Table 8 using the same metrics that
in Section C.1.
Table 8: Average performances and standard deviation (in parenthesis) on 100 sim-
ulated data for different dimension d with the times simuted with a mixture of
gammas. For each configuration, the best result appears in bold.
d model C-index AUC ‖β − βˆ‖1 ‖β − βˆ‖2
C-mix 0.701 (0.090) 0.659 (0.083) 51.339 (2.497) 7.186 (0.281)
CURE 0.682 (0.058) 0.609 (0.037) 51.563 (1.071) 7.263 (0.097)
200 Cox PH 0.664 (0.085) 0.605 (0.065) 199.337 (0.493) 99.686 (0.231)
AEnet 0.631 (0.062) 0.577 (0.046) 54.651 (2.328) 7.713 (0.426)
WEnet 0.620 (0.061) 0.544 (0.030) 58.861 (4.298) 8.568 (0.851)
C-mix 0.704 (0.100) 0.651 (0.084) 52.416 (2.311) 7.357 (0.231)
CURE 0.687 (0.057) 0.609 (0.038) 52.041 (1.667) 7.262 (0.096)
500 Cox PH 0.621 (0.101) 0.559 (0.057) 499.677 (0.381) 158.017 (0.113)
AEnet 0.604 (0.061) 0.557 (0.030) 55.126 (1.693) 7.616 (0.316)
WEnet 0.594 (0.065) 0.535 (0.021) 59.736 (2.777) 8.438 (0.626)
C-mix 0.684 (0.097) 0.638 (0.088) 52.557 (3.746) 7.331 (0.277)
CURE 0.658 (0.057) 0.603 (0.044) 53.120 (3.853) 7.273 (0.165)
1000 Cox PH 0.580 (0.092) 0.538 (0.053) 999.785 (0.334) 223.561 (0.071)
AEnet 0.586 (0.058) 0.541 (0.024) 54.597 (1.312) 7.495 (0.299)
WEnet 0.583 (0.054) 0.525 (0.017) 58.746 (2.260) 8.150 (0.551)
Hence, the C-mix model still gets the best results, both in terms of risk prediction
and variable selection. Note that AFT with AEnet and WEnet outperforms the Cox
model regularized by the Elastic-Net when d = 1000, but is still far behind the C-mix
performances.
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D Tuning of the censoring level
Suppose that we want to generate data following the procedure detailed in Section
4.2, in the C-mix with geometric distributions or CURE case. The question here is
to choose αc for a desired censoring rate rc, and for some fixed parameters α0, α1
and pi0. We write
1− rc = E[δ] =
+∞∑
k=0
+∞∑
j=1
[
α0(1− α0)j−1pi0 + α1(1− α1)j−1(1− pi0)
]
αc(1− αc)j+k−1
=
α0pi0
[
1− (1− α1)(1− αc)
]
+ α1(1− pi0)
[
1− (1− α0)(1− αc)
][
1− (1− α0)(1− αc)
][
1− (1− α1)(1− αc)
] .
Then, if we denote r¯c = 1−rc, α¯c = 1−αc, α¯0 = 1−α0, α¯1 = 1−α1 and p¯i0 = 1−pi0,
we can choose αc for a fixed rc by solving the following quadratic equation
(r¯c α¯0 α¯1)α¯
2
c +
(
α0pi0α¯1 + α1p¯i0 α¯0 − r¯c(α¯1 + α¯0)
)
α¯c + (rc − α0pi0 − α1p¯i0) = 0,
for which one can prove that there is always a unique root in (0, 1).
E Details on variable selection evaluation
Let us recall that the true underlying β used in the simulations is given by
β = (ν, . . . , ν︸ ︷︷ ︸
s
, 0, . . . , 0) ∈ Rd,
with s the sparsity parameter, being the number of “active” variables. To illustrate
how we assess the variable selection ability of the considered models, we give in
Figure 8 an example of β with d = 100, ν = 1 and s = 30. We simulate data
according to this vector (and to the C-mix model) with two different (gap, rcf )
values: (0.2, 0.7) and (1, 0.3). Then, we give the two corresponding estimated vectors
βˆ learned by the C-mix on this data.
Denoting β˜i = |βˆi|/max
{|βˆi|, i ∈ {1, . . . , d}}, we consider that β˜i is the predicted
probability that the true coefficient βi corresponding to i-th covariate equals ν.
Then, we are in a binary prediction setting where each β˜i predicts βi = ν for all
i ∈ {1, . . . , d}. We use the resulting AUC to assess the variable selection obtained
through βˆ.
F Extended simulation results
Table 9 bellow presents the results of simulation for the configurations (d, rc) =
(30, 0.2), (100,0.2) and (100,0.5).
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Figure 8: Illustration of the variable selection evaluation procedure. βˆ1 is learned
by the C-mix according to data generated with β and (gap, rcf ) = (0.2, 0.7). We
observe that using this gap value to generate data, the model does not succeed to
completely vanish the confusion variables (being 70% of the non-active variables,
represented in green color), while all other non-active variables are vanished. The
corresponding AUC scrore of feature selection is 0.73. βˆ2 is learned by the C-mix
according to data generated with β and (gap, rcf ) = (1, 0.3). The confusion variables
are here almost all detected and the corresponding AUC scrore of feature selection
is 0.98.
G Selected genes per model on the TCGA datasets
In Tables 10, 11 and 12 hereafter, we detail the 20 most significant covariates
for each model and for the three considered datasets. For each selected gene, we
precise the corresponding effect in percentage, where we define the effect of co-
variate j as 100 × |βj| / ‖β‖1 %. Then, to explore physiopathological and epi-
demiological background that could explain the role of the selected genes in cancer
prognosis, we search in MEDLINE (search performed on the 15th september 2016
at http://www.nlm.nih.gov/bsd/pmresources.html) the number of publications for
different requests: (1) selected gene name (e.g. UBTF), (2) selected gene name and
cancer (e.g. UBTF AND cancer[MesH]), (3) selected gene name and cancer survival
(e.g. UBTF AND cancer[MesH] AND survival). We then estimate f1 defined here
as the frequency of publication dealing with cancer among all publications for this
gene, i.e. (2)/(1), and f2 defined as the frequency of publication dealing with survival
among publications dealing with cancer, i.e. (3)/(2). A f1 (respectively f2) close to
1 just informs that the corresponding gene is well known to be highly related to
cancer (respectively to cancer survival) by the genetic research community. Note
that the CURE and Cox PH models tend to have a smaller support than the C-mix
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one, since they tend to select less than 20 genes.
Table 10: Top 20 selected genes per model for the BRCA cancer, with the corre-
sponding effects. Dots (·) mean zeros.
Genes Model effects (%) MEDLINE data
C-mix CURE Cox PH (1) f1 f2
PHKB|5257 9.8 7.2 4.3 1079 0.20 0.37
UBTF|7343 7.8 5.8 21.7 14 0,21 ·
LOC100132707 5.7 3.9 18.8 · · ·
CHTF8|54921 4.4 · 7.2 1 1 ·
NFKBIA|4792 4.3 1.9 3.4 247 0.27 0.22
EPB41L4B|54566 3.6 2.6 · 19 0.47 0.22
UGP2|7360 3.6 2.2 · 19 0.15 1
DPY19L2P1|554236 3.3 · 3.3 1 · ·
TRMT2B|79979 3.3 2.2 · · · ·
HSD3B7|80270 3.2 1.9 7.6 19 0.05 ·
DLAT|1737 3.2 2.9 · 75 0.16 0.16
NIPAL2|79815 2.8 1.9 · · · ·
FGD3|89846 2.7 · 5.9 10 0.2 0.5
JRKL|8690 2.7 2.6 · 2 · ·
ZBED1|9189 2.5 2.4 · 6 · ·
KCNJ11|3767 2.3 · · 647 0.02 ·
WAC|51322 2.0 3.2 · 260 0.05 0.25
FLT3|2322 2.0 · · 4435 0.55 0.42
STK3|6788 1.9 2.3 · 107 0.32 0.15
PAOX|196743 1.9 1.9 · 18 0.11 ·
C14orf68|283600 · 3.3 · · · ·
LIN7C|55327 · 3.1 · 36 0.06 ·
PNRC2|55629 · 2.1 · 15 · ·
SLC39A7|7922 · 1.8 · 22 0.18 ·
MAGT1|84061 · 1.7 · 50 0.12 0.17
IRF2|3660 · · 10.9 310 0.21 0.14
PELO|53918 · · 7.0 265 0.08 0.04
SUSD3|203328 · · 5.3 5 0.6 0.67
LEF1|51176 · · 3.2 940 0.29 0.23
CPA4|51200 · · 1.4 18 0.22 ·
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Table 11: Top 20 selected genes per model for the GBM cancer, with the corre-
sponding effects. Dots (·) mean zeros.
Genes Model effects (%) MEDLINE data
C-mix CURE Cox PH (1) f1 f2
ARMCX6|54470 4.9 · 23.6 1 · ·
FAM35A|54537 4.4 · 21.8 · · ·
CLEC4GP1|440508 3.9 5.1 2.8 · · ·
INSL3|3640 3.6 2.7 1.7 404 0.06 0.12
REM1|28954 3.2 · · 54 0.05 0.66
FAM35B2|439965 3.0 · · · · ·
TSPAN4|7106 2.7 · · 16 0.31 0.4
AP3M1|26985 2.7 · · 2 0.5 ·
PXN|5829 2.6 · 15.4 891 0.25 0.18
PDE4C|5143 2.5 · · 67 0.06 0.25
PGBD5|79605 2.5 · · 5 0.25 ·
NRG1|3084 2.4 · 18.5 1207 0.12 0.29
LOC653786 2.2 · · · · ·
FERMT1|55612 2.1 · · 115 0.19 0.18
PLD3|23646 2.0 · · 38 0.10 0.25
MIER1|57708 1.9 · 2.1 16 0.31 ·
UTP14C|9724 1.8 · · 5 0.4 ·
AZU1|566 1.8 · · 15 0.2 0.33
KCNC4|3749 1.7 · · 30 0.1 0.33
FAM35B|414241 1.6 · · · · ·
CRELD1|78987 · 32.2 · 32 0.03 ·
HMGN5|79366 · 21.2 · 41 0.54 0.32
PNLDC1|154197 · 12.2 · 3 · ·
LOC493754 · 9.8 · · · ·
KIAA0146|23514 · 8.7 · 3 0.67 ·
TMCO655374 · 3.6 · 4 0.25 ·
ABLIM1|3983 · 2.1 · 20 0.2 ·
OSBPL11|114885 · 1.0 · · · ·
TRAPPC1|58485 · 0.9 · 4 0.75 ·
TBCEL|219899 · 0.5 · 7 0.28 ·
RPL39L|116832 · · 8.8 10 0.7 0.14
GALE|2582 · · 3.5 540 0.02 ·
BBC3|27113 · · 0.7 561 0.54 0.38
DUSP6|1848 · · 0.6 307 0.30 0.22
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Table 12: Top 20 selected genes per model for the KIRC cancer, with the corre-
sponding effects. Dots (·) mean zeros.
Genes Model effects (%) MEDLINE data
C-mix CURE Cox PH (1) f1 f2
BCL2L12|83596 8.6 2.7 · 64 0.72 0.39
MARS|4141 7.5 6.9 7.2 577 0.02 0.1
NUMBL|9253 7.2 28.6 3.3 56 0.14 0.25
CKAP4|10970 6.1 10.6 22.3 825 0.63 0.11
HN1|51155 5.8 3.8 · 13 0.38 0.2
GIPC2|54810 5.7 · · 15 0.6 0.11
NPR3|4883 5.2 · · 105 0.05 0.6
GBA3|57733 5.0 · · 19 0.10 ·
SLC47A1|55244 5.0 · · 70 0.06 ·
ALDH3A2|224 4.7 · 2.6 52 0.06 0.33
CCNF|899 4.2 2.8 · 50 0.24 0.08
EHHADH|1962 3.9 · · 90 0.1 ·
SGCB|6443 3.3 · · 30 · ·
GFPT2|9945 2.7 1.3 · 18 0.22 0.25
PPAP2B|8613 2.3 · · 29 0.17 0.2
MBOAT7|79143 1.9 13.8 11.1 15 · ·
OSBPL1A|114876 1.5 · · 7 · ·
C16orf57|79650 1.2 · · 26 · ·
ATXN7L3|56970 0.9 2.5 · 9 · ·
C16orf59|80178 0.8 · · 3 0.66 ·
STRADA92335 · 20.7 53.5 9 · ·
ABCC10|89845 · 3.9 · 80 0.32 0.23
MDK|4192 · 1.2 · 789 0.38 0.23
C16orf59|80178 · 1.1 · 3 0.6 ·
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